Published on in Vol 6, No 3 (2022): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33073, first published .
Patient- and Provider-Reported Experiences of a Mobile Novel Digital Therapeutic in People With Opioid Use Disorder (reSET-O): Feasibility and Acceptability Study

Patient- and Provider-Reported Experiences of a Mobile Novel Digital Therapeutic in People With Opioid Use Disorder (reSET-O): Feasibility and Acceptability Study

Patient- and Provider-Reported Experiences of a Mobile Novel Digital Therapeutic in People With Opioid Use Disorder (reSET-O): Feasibility and Acceptability Study

Sarah Kawasaki   1 , MD ;   Sara Mills-Huffnagle   1 , MA ;   Nicole Aydinoglo   2 , BA ;   Halley Maxin   1 , BA ;   Edward Nunes   2 , MD

1 Department of Psychiatry and Behavioral Health, Penn State Health, Hershey, PA, United States

2 Department of Psychiatry, Columbia University, New York, NY, United States

Corresponding Author:

  • Sarah Kawasaki, MD
  • Department of Psychiatry and Behavioral Health
  • Penn State Health
  • 500 University Drive
  • Box H073
  • Hershey, PA, 17033
  • United States
  • Phone: 1 7177826844
  • Fax: 1 7172215674
  • Email: skawasaki@pennstatehealth.psu.edu